Abstract
The treatment of patients with follicular lymphoma is undergoing a substantial shift due to rapid development of highly effective agents targeting lymphoma-specific biologic processes and the tumor microenvironment.
Original language | English (US) |
---|---|
Pages (from-to) | 769-772 |
Number of pages | 4 |
Journal | ONCOLOGY (United States) |
Volume | 29 |
Issue number | 10 |
State | Published - Oct 15 2015 |
ASJC Scopus subject areas
- Oncology
- Cancer Research